U.S. flag

An official website of the United States government

NM_152263.4(TPM3):c.503G>A (p.Arg168His) AND Congenital myopathy 4A, autosomal dominant

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Oct 1, 2009
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000054415.27

Allele description [Variation Report for NM_152263.4(TPM3):c.503G>A (p.Arg168His)]

NM_152263.4(TPM3):c.503G>A (p.Arg168His)

Gene:
TPM3:tropomyosin 3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q21.3
Genomic location:
Preferred name:
NM_152263.4(TPM3):c.503G>A (p.Arg168His)
HGVS:
  • NC_000001.11:g.154172971C>T
  • NG_008621.1:g.24163G>A
  • NM_001043351.2:c.392G>A
  • NM_001043352.2:c.392G>A
  • NM_001043353.2:c.392G>A
  • NM_001278188.2:c.194G>A
  • NM_001278189.2:c.392G>A
  • NM_001278190.2:c.392G>A
  • NM_001278191.2:c.122G>A
  • NM_001349679.2:c.392G>A
  • NM_001364679.2:c.503G>A
  • NM_001364680.2:c.503G>A
  • NM_001364681.2:c.503G>A
  • NM_001364682.1:c.503G>A
  • NM_001364683.1:c.392G>A
  • NM_152263.4:c.503G>AMANE SELECT
  • NM_153649.4:c.392G>A
  • NP_001036816.1:p.Arg131His
  • NP_001036817.1:p.Arg131His
  • NP_001036818.1:p.Arg131His
  • NP_001265117.1:p.Arg65His
  • NP_001265118.1:p.Arg131His
  • NP_001265119.1:p.Arg131His
  • NP_001265120.1:p.Arg41His
  • NP_001336608.1:p.Arg131His
  • NP_001351608.1:p.Arg168His
  • NP_001351609.1:p.Arg168His
  • NP_001351610.1:p.Arg168His
  • NP_001351611.1:p.Arg168His
  • NP_001351612.1:p.Arg131His
  • NP_689476.2:p.Arg168His
  • NP_705935.1:p.Arg131His
  • LRG_681t1:c.392G>A
  • LRG_681t2:c.503G>A
  • LRG_681t3:c.392G>A
  • LRG_681:g.24163G>A
  • LRG_681p1:p.Arg131His
  • LRG_681p2:p.Arg168His
  • LRG_681p3:p.Arg131His
  • NC_000001.10:g.154145447C>T
  • NM_152263.2:c.503G>A
  • NM_152263.3:c.503G>A
  • NR_103461.2:n.491G>A
  • P06753:p.Arg168His
  • p.(Arg168His)
Protein change:
R131H; ARG168HIS
Links:
UniProtKB: P06753#VAR_070069; OMIM: 191030.0005; dbSNP: rs121964852
NCBI 1000 Genomes Browser:
rs121964852
Molecular consequence:
  • NM_001043351.2:c.392G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001043352.2:c.392G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001043353.2:c.392G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001278188.2:c.194G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001278189.2:c.392G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001278190.2:c.392G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001278191.2:c.122G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001349679.2:c.392G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001364679.2:c.503G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001364680.2:c.503G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001364681.2:c.503G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001364682.1:c.503G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001364683.1:c.392G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_152263.4:c.503G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_153649.4:c.392G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NR_103461.2:n.491G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Congenital myopathy 4A, autosomal dominant
Synonyms:
Nemaline myopathy 1; Cap myopathy 1
Identifiers:
MONDO: MONDO:0800341; MedGen: CN178536; OMIM: 255310

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000033510OMIM
no assertion criteria provided
Pathogenic
(Oct 1, 2009)
germlineliterature only

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

A second pedigree with autosomal dominant nemaline myopathy caused by TPM3 mutation: a clinical and pathological study.

PĂ©nisson-Besnier I, Monnier N, Toutain A, Dubas F, Laing N.

Neuromuscul Disord. 2007 Apr;17(4):330-7. Epub 2007 Mar 21.

PubMed [citation]
PMID:
17376686

Mutations in TPM3 are a common cause of congenital fiber type disproportion.

Clarke NF, Kolski H, Dye DE, Lim E, Smith RL, Patel R, Fahey MC, Bellance R, Romero NB, Johnson ES, Labarre-Vila A, Monnier N, Laing NG, North KN.

Ann Neurol. 2008 Mar;63(3):329-37. doi: 10.1002/ana.21308.

PubMed [citation]
PMID:
18300303
See all PubMed Citations (4)

Details of each submission

From OMIM, SCV000033510.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (4)

Description

In 4 affected members of a French family with autosomal dominant congenital myopathy-4A (CMYO4A; 255310), Penisson-Besnier et al. (2007) identified a heterozygous c.503G-A transition in exon 5 of the TPM3 gene, resulting in an ARG167HIS substitution. Although most patients had symptoms in childhood, all remained ambulatory as adults. Clarke et al. (2008) noted that based on numbering from the first met codon this mutation is designated ARG168HIS (R168H).

In a father and daughter with congenital myopathy, Clarke et al. (2008) identified the R168H mutation in the TPM3 gene. Both patients had onset of hypotonia in infancy and were able to run in late adolescence. At age 60, the father could walk, had impaired nocturnal ventilation, showed distal more than proximal weakness, and had scoliosis with lumbar lordosis. Skeletal muscle biopsy was consistent with nemaline myopathy. At age 20, the daughter was able to run, had decreased forced vital capacity, mild proximal weakness, and mild scoliosis. Skeletal muscle biopsy showed fiber-type disproportion (CFTD) The findings of both nemaline myopathy and CFTD in patients with the same mutation showed that TPM3 mutations can cause a range of histologic changes, and suggested that there is a close relation between nemaline myopathy and CFTD.

De Paula et al. (2009) reported a 42-year-old man with the R168H mutation who showed cap myopathy on skeletal muscle biopsy. He had hypotonia in the first months of life, delayed motor development, and distal weakness of the lower limbs with frequent falls in childhood. At age 7 years, he had flat feet in valgus, long narrow face, high-arched palate, and mild lumbar hyperlordosis. Tendon reflexes were absent. The clinical course was stable until presentation at age 42 with inability to run, difficulty climbing stairs, and predominant distal muscle weakness. Skeletal muscle biopsy at age 7 years showed type 1 fiber hypotrophy. Biopsy at age 42 years showed only type 1 fibers, irregularity of fiber size, occasional central nuclei, and peripheral eosinophilic-basophilic densely stained substances consistent with 'caps.' The caps were present in about 10 to 15% of muscle fibers, were negative for ATPase staining, were present just beneath the sarcolemma, and consisted of abnormally arranged myofibrils. Z-lines were thickened with some rod-like structures. The authors noted that this case had first been reported as a congenital myopathy with selective hypotrophy of type 1 fibers (Serratrice et al., 1975), and that the biopsy results discussed in that report would have been consistent with CFTD. The findings suggested a relationship between nemaline myopathy, CFTD, and cap myopathy, and indicated that cap structures may develop over time.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 24, 2024